Opioid receptor and peptide gene polymorphisms: potential implications for addictions

By LaForge K.S.   Yuferov V.   Kreek M.J.  

European Journal of Pharmacology, Vol. 410, Iss. 2, 2000-12 ,pp. : 249-268

Elsevier

Access to resources Recommend Favorite

Corrigendum to ''Neuropharmacological profiles of a novel atypical antipsychotic, NRA0562, in rats'' [Eur. J. Pharmacol. 423 (2001) 27-33]

By Kawashima N.   Funakoshi T.   Omura T.   Chaki S.   Kameo K.   Okuyama S.  

European Journal of Pharmacology, Vol. 428, Iss. 3, 2001-10 ,pp. : 389-390

Elsevier

Access to resources Recommend Favorite

Corrigendum to ''Interaction of human organic anion transporters with various cephalosporin antibiotics'' [Eur. J. Pharmacol. 438 (2001) 137-142]

By Takeda M.   Babu E.   Narikawa S.   Endou H.  

European Journal of Pharmacology, Vol. 450, Iss. 1, 2002-08 ,pp. : 111-111

Elsevier

Access to resources Recommend Favorite

Corrigendum to ''The effects of tubulin-binding agents on stretch-induced ventricular arrhythmias'' [Eur. J. Pharmacol. 417 (2001) 131-140]

By Parker K.K.   Taylor L.K.   Atkinson J.B.   Hansen D.E.   Wikswo J.P.  

European Journal of Pharmacology, Vol. 426, Iss. 3, 2001-08 ,pp. : 207-207

Elsevier

Access to resources Recommend Favorite

Erratum to: ''Enhanced -opioid receptor-mediated antinociception in -opioid receptor-deficient mice'' - [Eur. J. Pharmacol. 387 (2000) 163-169] 1

By Qiu C.   Sora I.   Ren K.   Uhl G.   Dubner R.  

European Journal of Pharmacology, Vol. 397, Iss. 1, 2000-05 ,pp. : 227-227

Elsevier

Access to resources Recommend Favorite